Georgie Mathew

Georgie Mathew is a passionate and forward-thinking executive with a strong track record in building high-performance organizations, delivering results, enforcing accountability, and leading business processes in various sectors such as Commercial, R&D, Clinical/Medical, and Consumer.

Georgie is a Certified Six Sigma and Project Management Professional, excelling in continuous process and performance improvements, new product launches, capacity management, strategic planning, governance, and organizational development.

Specializing in areas including Cardiovascular, Diabetes, Dermatology, Oncology, Infectious Diseases, Biologics, Pain, Rheumatology, and Vaccines, Georgie has a diverse skill set and expertise in a range of healthcare domains.

Education-wise, Georgie pursued an Executive MBA in Pharmaceutical Marketing from Saint Joseph's University - Erivan K. Haub School of Business, MODL in Organizational Development and Leadership, MBMS in Biomedical Sciences from Philadelphia College of Osteopathic Medicine, and a BA in Biology from Temple University. Additionally, Georgie studied Business Management at Harvard University and completed their High School Diploma at Central High School.

Georgie has held various key positions in renowned organizations, having been the Head of Vendor Strategy, Program Lead (R&D/Med/Clin), and Director of Portfolio and Innovation at Johnson & Johnson. Prior to this, Georgie served as the Head of the Program Management Office at Novartis, US Commercial PMO at Novartis, and Oncology R&D PMO at Novartis. Georgie also has experience from roles such as Clinical Research Specialist II/Associate Project Manager at Merck & Co., Senior Clinical Coordinator II at Covance, and various clinical roles at PCOM and Associate Program Director at Temple University.